XML 30 R8.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Statements of Stockholders' Equity - USD ($)
Total
Adjustment
Preferred stock
Common stock
Additional paid-in capital
Additional paid-in capital
Adjustment
Accumulated deficit
Accumulated deficit
Adjustment
Accumulated other comprehensive loss
Beginning balance (in shares) at Dec. 31, 2020     9 15,570,957 [1]          
Beginning balance at Dec. 31, 2020 $ 461,140,758   $ 0 $ 15,571 [1] $ 1,367,578,149   $ (906,196,812)   $ (256,150)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Issuance of common stock for cash, net of financing costs (in shares) [1]       2,275,861          
Issuance of common stock for cash, net of financing costs 209,441,410     $ 2,276 [1] 209,439,134        
Conversion of preferred stock/senior notes to common stock (in shares) [1]       84,120          
Conversion of preferred stock/senior notes to common stock 4,377,892     $ 84 [1] 4,377,808        
Exercise of stock options and warrants for cash and vesting of RSUs, net of tax payments (in shares) [1]       184,299          
Exercise of stock options for cash and vesting of RSUs, net of tax payments 2,057,393     $ 184 [1] 2,057,209        
Stock-based compensation 26,336,764       26,336,764        
Net loss (303,658,710)           (303,658,710)    
Unrealized gain (loss) on short-term investments, net of tax 4,048               4,048
Foreign currency translation (30,134)               (30,134)
Ending balance at Dec. 31, 2021 399,669,421 $ (1,468,216) $ 0 $ 18,115 [1] 1,609,789,064 $ (3,294,019) (1,209,855,522) $ 1,825,803 (282,236)
Ending balance (in shares) at Dec. 31, 2021     9 18,115,237 [1]          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Issuance of common stock for cash, net of financing costs (in shares) [1]       2,870,478          
Issuance of common stock for cash, net of financing costs 82,955,311     $ 2,870 [1] 82,952,441        
Exercise of stock options and warrants for cash and vesting of RSUs, net of tax payments (in shares) [1]       105,223          
Exercise of stock options for cash and vesting of RSUs, net of tax payments (1,114,609)     $ 105 [1] (1,114,714)        
Stock-based compensation 22,555,419       22,555,419        
Net loss (279,818,065)           (279,818,065)    
Unrealized gain (loss) on short-term investments, net of tax (390,949)               (390,949)
Foreign currency translation (25,556)               (25,556)
Ending balance at Dec. 31, 2022 222,362,756   $ 0 $ 21,090 [1] 1,710,888,191   (1,487,847,784)   (698,741)
Ending balance (in shares) at Dec. 31, 2022     9 21,090,938 [1]          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Issuance of common stock for legal settlement (in shares) [1]       760,083          
Issuance of common stock for legal settlement 14,000,000     $ 760 [1] 13,999,240        
Issuance of common stock for cash, net of financing costs (in shares) [1]       875,305          
Issuance of common stock for cash, net of financing costs 5,461,745     $ 875 [1] 5,460,870        
Exercise of stock options and warrants for cash and vesting of RSUs, net of tax payments (in shares) [1]       66,749          
Exercise of stock options for cash and vesting of RSUs, net of tax payments (466,646)     $ 67 [1] (466,713)        
Stock-based compensation 11,072,486       11,072,486        
Net loss (135,117,352)           (135,117,352)    
Unrealized gain (loss) on short-term investments, net of tax 40,060               40,060
Foreign currency translation (3,920)               (3,920)
Ending balance at Dec. 31, 2023 $ 117,349,129   $ 0 $ 22,792 [1] $ 1,740,954,074   $ (1,622,965,136)   $ (662,601)
Ending balance (in shares) at Dec. 31, 2023     9 22,793,075 [1]          
[1]
(1) All share amounts in this column, including appropriate reclassifications between common stock and additional paid-in capital, have been restated to reflect the 1-for-12 reverse stock split effected in January 2024 on a retroactive basis for all periods presented.